Recent 8-K filings for TLSI

• May 12, 2026 20:03 UTC earnings materiality 0.75 negative item 2.02item 9.01

  TriSalus Q1 revenue $8.9M (-2.9% YoY); revises FY 2026 guidance to $54-57M

  Revenue $8.9M, down 2.9% YoY; gross margin improved to 86.2% from 83.7%.

• Mar 05, 2026 23:59 UTC earnings materiality 0.75 positive item 2.02item 9.01

  TriSalus Q4 revenue $13.2M (+60% YoY); reaffirms 2026 revenue guidance $60-62M

  Full-year 2025 revenue $45.2M (+53% YoY); Q4 gross margin 86.7% vs 85.3% prior year.

• Feb 20, 2026 23:59 UTC other_material materiality 0.70 neutral item 1.01item 8.01item 9.01

  TriSalus prices $40M public offering of 9.76M shares at $4.10/share

  Gross proceeds ~$40.0M from 9,756,100 shares at $4.10/share; net proceeds ~$37.0M (before over-allotment).

• Jan 12, 2026 23:59 UTC earnings materiality 0.70 positive item 2.02item 9.01

  TriSalus reports Q4 revenue $13.2M (+60% YoY), FY25 $45.2M (+53%), FY26 guidance $60-62M

  Q4 2025 revenue approx $13.2M vs $8.3M year ago, up 60% YoY; full-year revenue approx $45.2M vs $29.4M, up 53% YoY.

• Nov 13, 2025 23:59 UTC earnings materiality 0.70 neutral item 2.02item 9.01

  TriSalus Q3 revenue $11.6M (+57% YoY); net loss $41.3M on preferred conversion; reaffirms 50% FY growth

  Revenue $11.6M, up 57% YoY and 3% sequentially; all from TriNav liver embolization.

• Aug 12, 2025 23:59 UTC earnings materiality 0.70 positive item 2.02item 9.01

  TriSalus Q2 revenue $11.2M (+52% YoY); reaffirms 50% FY growth; net loss $9.0M

  Revenue $11.2M, +52% YoY, +22% sequential; gross margin 84% vs 88%.

• Jul 24, 2025 23:59 UTC other_material materiality 0.75 neutral item 3.03item 5.03item 5.07item 8.01item 9.01

  TriSalus completes Preferred Stock exchange; 98.82% tendered at 3.3 common shares each

  Approximately 98.82% of outstanding Series A Convertible Preferred Stock (3,551,502 shares) validly tendered in exchange offer.

• Jun 23, 2025 23:59 UTC other_material materiality 0.65 neutral item 8.01item 9.01

  TriSalus launches exchange offer for Series A Preferred, up to 11.9M common shares

  Offers up to 11,860,206 common shares in exchange for each share of Series A Convertible Preferred at $4.00 per share based on liquidation preference plus accrued dividends through Aug 10, 2027.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.75 · Median 0.60 · Most common event leadership

3 positive 1 negative 12 neutral

source · TLSI on sec.gov